Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
03/29/2016
|
ACAD |
|
Advisory Panel |
Neurology |
Breakthrough Therapy, Priority Review |
|
05/01/2016
|
ACAD |
|
PDUFA |
Neurology |
Breakthrough Therapy, Priority Review |
|
10/22/2016
|
MDVN |
|
PDUFA |
Oncology |
None |
|
12/11/2016
|
SPPI |
|
PDUFA |
Oncology |
None |
|
01/03/2017
|
VCEL |
|
PDUFA |
Other |
None |
|
10/14/2016
|
EGLT |
|
PDUFA |
Neurology |
None |
|
01/07/2017
|
ANAC |
|
PDUFA |
Other |
None |
|
09/15/2016
|
DVAX |
|
PDUFA |
Infectious Disease |
None |
|
04/25/2016
|
SRPT |
|
Advisory Panel |
Other |
Fast Track, Orphan Drug, Priority Review, Rare Pediatric Disease |
|
05/26/2016
|
SRPT |
|
PDUFA |
Other |
Fast Track, Orphan Drug, Priority Review, Rare Pediatric Disease |
|